Last updated: 2025-12-10 09:02:04 ET
No hourly mention data available.
With SpaceX’s valuation expected to skyrocket, its CEO largely credits satellites, rocket launches — and the company’s plan to solve a major AI...
Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron, that just showed positive results from a Phase 2 trial.
SpaceX has informed investors and representatives of financial institutions that it plans to pursue an initial public offering in the second half of n...
The rocket-launch company is also reportedly eyeing a public debut.
While Intuitive Machines and Rocket Lab shares have diverged this year, Cantor Fitzgerald sees room for both to surge in 2026.
